EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Synchron is a neurotechnology company that aims to transform medicine with unprecedented access to brain data. They are developing a breakthrough platform that enables people to use their thoughts to control digital devices.
Beyond the Chatbot: Why the Future of AI Needs to See What You See
Synchron Announces $200M Series D Round
China’s Brain-Computer Interface Industry Is Racing Ahead
Synchron Raises $200M in Series D Round